MARKET

BRKR

BRKR

Bruker
NASDAQ

Real-time Quotes | Nasdaq Last Sale

83.35
+0.09
+0.11%
After Hours: 83.35 0 0.00% 16:31 09/17 EDT
OPEN
83.64
PREV CLOSE
83.26
HIGH
84.24
LOW
82.37
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
92.35
52 WEEK LOW
37.27
MARKET CAP
12.59B
P/E (TTM)
53.91
1D
5D
1M
3M
1Y
5Y
Is Senseonics a Buy Under $4?
StockNews.com · 1d ago
SVB Leerink Maintains Outperform on Bruker, Raises Price Target to $100
SVB Leerink analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $90 to $100.
Benzinga · 09/09 12:34
Glycomics / Glycobiology Market is Booming Worldwide by Global Demand Analysis & Opportunity Outlook 2028
Research Nester published a report titled which delivers a detailed overview of the global glycomics / glycobiology market in terms of market segmentation by product, application, end-user and by region.
AmericaNewsHour · 09/07 11:47
Bruker (BRKR) Up 9.3% Since Last Earnings Report: Can It Continue?
Zacks.com · 09/01 15:30
Profitable stocks plays off the beaten path
JoAnne Feeney, Advisors Capital Management, joins Fast Money Special Edition to discuss profitable stocks that are lesser known.
CNBC.com · 08/31 22:55
Bruker Corporation to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
BILLERICA, Mass., August 30, 2021--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer, and Falko Busse, President of...
Business Wire · 08/30 20:10
Here's Why We Think Bruker (NASDAQ:BRKR) Is Well Worth Watching
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Simply Wall St. · 08/27 10:38
Bruker (BRKR) Hits a New 52-Week High: What's Driving It?
Zacks.com · 08/23 12:43
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BRKR. Analyze the recent business situations of Bruker through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BRKR stock price target is 83.58 with a high estimate of 100.00 and a low estimate of 68.00.
EPS
Institutional Holdings
Institutions: 436
Institutional Holdings: 112.58M
% Owned: 74.55%
Shares Outstanding: 151.02M
TypeInstitutionsShares
Increased
96
6.94M
New
60
1.60M
Decreased
86
8.13M
Sold Out
23
548.73K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Director/President/Chief Executive Officer
Frank Laukien
Chief Financial Officer
Gerald Herman
Corporate Executive
Falko Busse
Corporate Executive
Burkhard Prause
Corporate Executive
Juergen Srega
Executive Vice President
Mark Munch
Lead Director/Independent Director
William Linton
Independent Director
Bonnie Anderson
Independent Director
Cynthia Friend
Independent Director
Marc Kastner
Independent Director
John Ornell
Independent Director
Richard Packer
Independent Director
Adelene Perkins
Independent Director
Hermann Requardt
Independent Director
Robert Rosenthal
Declaration Date
Dividend Per Share
Ex-Div Date
05/13/2021
Dividend USD 0.04
05/28/2021
02/18/2021
Dividend USD 0.04
03/04/2021
11/13/2020
Dividend USD 0.04
11/30/2020
08/07/2020
Dividend USD 0.04
08/31/2020
05/12/2020
Dividend USD 0.04
05/29/2020
02/20/2020
Dividend USD 0.04
03/06/2020
11/14/2019
Dividend USD 0.04
11/29/2019
08/12/2019
Dividend USD 0.04
08/30/2019
05/10/2019
Dividend USD 0.04
05/31/2019
02/15/2019
Dividend USD 0.04
03/04/2019
--
Dividend USD 0.04
11/30/2018
--
Dividend USD 0.04
08/31/2018
--
Dividend USD 0.04
06/01/2018
--
Dividend USD 0.04
03/05/2018
--
Dividend USD 0.04
12/01/2017
--
Dividend USD 0.04
08/31/2017
--
Dividend USD 0.04
06/01/2017
02/21/2017
Dividend USD 0.04
03/06/2017
11/10/2016
Dividend USD 0.04
12/01/2016
--
Dividend USD 0.04
09/01/2016
About BRKR
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Webull offers kinds of Bruker Corporation stock information, including NASDAQ:BRKR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRKR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BRKR stock methods without spending real money on the virtual paper trading platform.